Showing results (1611-1620 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|July 31, 2013
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathwayChiara Riganti, Iris Chiara Salaroglio, Valentina Caldera, et al.
Neuro-Oncology|June 14, 2012
Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogramHee Kyung Ahn, Soohyeon Lee, Yeon Hee Park, et al.
Neuro-Oncology|November 20, 2012
Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Matthias Kolberg, Maren Høland, Trude H Agesen, et al.
Neuro-Oncology|November 20, 2012
MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2Cheng-Ying Ho, Eli Bar, Caterina Giannini, et al.
Neuro-Oncology|December 25, 2014
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade gliomaPer Munck Af Rosenschold, Junia Costa, Svend Aage Engelholm, et al.
Neuro-Oncology|December 29, 2014
Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanismsMartin Zamykal, Tobias Martens, Jakob Matschke, et al.
Neuro-Oncology|July 6, 2014
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumorsKatherine S Panageas, Anne S Reiner, Fabio M Iwamoto, et al.
Neuro-Oncology|August 21, 2014
Efficacy of cabazitaxel in mouse models of pediatric brain tumorsEmily Girard, Sally Ditzler, Donghoon Lee, et al.
Neuro-Oncology|August 21, 2014
Periostin is a novel therapeutic target that predicts and regulates glioma malignancyAndrei M Mikheev, Svetlana A Mikheeva, Andrew D Trister, et al.
Neuro-Oncology|September 11, 2015
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trialHendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, et al.
Pageof 316